Brooke Story - 14 Jun 2021 Form 3 Insider Report for Sigilon Therapeutics, Inc.

Role
Director
Signature
/s/ Matthew Kowalsky, Attorney-in-Fact
Issuer symbol
N/A
Transactions as of
14 Jun 2021
Net transactions value
$0
Form type
3
Filing time
16 Jun 2021, 16:05:18 UTC
Next filing
27 May 2022

No securities are beneficially owned.